Whittier Trust Co. raised its stake in Steris Corp. (NYSE:STE) by 1.2% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 18,009 shares of the company’s stock after buying an additional 219 shares during the period. Whittier Trust Co.’s holdings in Steris Corp. were worth $1,238,000 as of its most recent filing with the SEC.
Other large investors have also made changes to their positions in the company. American Century Companies Inc. boosted its stake in shares of Steris Corp. by 870.8% in the second quarter. American Century Companies Inc. now owns 1,208,491 shares of the company’s stock valued at $83,084,000 after buying an additional 1,084,007 shares during the period. Villere ST Denis J & Co. LLC acquired a new stake in shares of Steris Corp. during the second quarter valued at about $46,505,000. Bank of Montreal Can acquired a new stake in shares of Steris Corp. during the second quarter valued at about $22,429,000. Royal Bank of Canada boosted its stake in shares of Steris Corp. by 109.5% in the first quarter. Royal Bank of Canada now owns 468,134 shares of the company’s stock valued at $33,261,000 after buying an additional 244,710 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in shares of Steris Corp. by 43.9% in the first quarter. JPMorgan Chase & Co. now owns 616,502 shares of the company’s stock valued at $43,802,000 after buying an additional 187,935 shares during the period. 91.58% of the stock is currently owned by institutional investors.
Steris Corp. (NYSE:STE) traded up 1.38% on Monday, hitting $72.25. The stock had a trading volume of 237,304 shares. The stock has a market cap of $6.22 billion, a price-to-earnings ratio of 41.50 and a beta of 1.13. Steris Corp. has a one year low of $61.38 and a one year high of $78.77. The stock’s 50 day moving average is $71.44 and its 200 day moving average is $70.40.
Steris Corp. (NYSE:STE) last released its quarterly earnings data on Tuesday, August 9th. The company reported $0.79 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.77 by $0.02. The firm earned $638.40 million during the quarter, compared to analysts’ expectations of $639.04 million. Steris Corp. had a return on equity of 10.72% and a net margin of 5.52%. Steris Corp.’s revenue was up 45.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.62 earnings per share. Analysts anticipate that Steris Corp. will post $3.90 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 27th. Shareholders of record on Tuesday, August 30th were given a $0.28 dividend. This is a boost from Steris Corp.’s previous quarterly dividend of $0.25. The ex-dividend date was Friday, August 26th. This represents a $1.12 annualized dividend and a yield of 1.55%. Steris Corp.’s dividend payout ratio is presently 68.71%.
Separately, Zacks Investment Research lowered Steris Corp. from a “hold” rating to a “sell” rating in a report on Wednesday, September 14th.
In other Steris Corp. news, VP Sudhir K. Pahwa sold 1,028 shares of the stock in a transaction on Friday, August 26th. The stock was sold at an average price of $70.13, for a total value of $72,093.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Daniel A. Carestio sold 2,681 shares of the stock in a transaction on Friday, August 12th. The stock was sold at an average price of $71.04, for a total value of $190,458.24. The disclosure for this sale can be found here. 2.52% of the stock is owned by company insiders.
About Steris Corp.
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Corp. (NYSE:STE).
Receive News & Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related companies with MarketBeat.com's FREE daily email newsletter.